To Örebro University

Co-medication and polypharmacy with ADHD medications in adults: a Swedish nationwide study 2020 (English)In: European Neuropsychopharmacology, ISSN 0924-977X, E-ISSN 1873-7862, Vol. 40, no Suppl. 1, p. S28-S29Article in journal, Meeting abstract (Other academic) Published

Place, publisher, year, edition, pages

Elsevier, 2020. Vol. 40, no Suppl. 1, p. S28-S29

National Category

Neurology

Identifiers

URN: urn:nbn:se:oru:diva-88679DOI: 10.1016/j.euroneuro.2020.09.043ISI: 000593520800037OAI: oai:DiVA.org:oru-88679DiVA, id: diva2:1520168

Conference

33rd Congress of the European-College-of-Neuropsychopharmacology (ECNP), Electronic Network, September 12-15, 2020

Funder

Forte, Swedish Research Council for Health, Working Life and Welfare, 2019-01172

Note

Funding Agencies:

European Union's Horizon 2020 research and innovation programme: Comorbid Conditions of ADHD CoCA 667302

United States Department of Health & Human Services

National Institutes of Health (NIH) - USA

NIH National Institute of Mental Health (NIMH) R01MH102221

Available from: 2021-01-20 Created: 2021-01-20 Last updated: 2021-01-20Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records

Larsson, Henrik

Search in DiVA

By author/editor

Larsson, Henrik

By organisation

School of Medical Sciences

In the same journal

European Neuropsychopharmacology

On the subject

Neurology

Search outside of DiVA

GoogleGoogle ScholarTotal: 91 hits